{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:44:00Z","timestamp":1762505040464,"version":"build-2065373602"},"reference-count":33,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1016\/j.clon.2005.07.005","type":"journal-article","created":{"date-parts":[[2005,8,27]],"date-time":"2005-08-27T07:08:27Z","timestamp":1125126507000},"page":"498-502","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["A Second Look at the pT1 G3 Bladder Tumour"],"prefix":"10.1016","volume":"17","author":[{"given":"S.J.","family":"Harland","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clon.2005.07.005_bib1","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1464-410X.1989.tb05967.x","article-title":"The pT1 G3 bladder tumour","volume":"64","author":"Birch","year":"1989","journal-title":"Br J Urol"},{"key":"10.1016\/j.clon.2005.07.005_bib2","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1002\/1097-0142(19830501)51:9<1710::AID-CNCR2820510925>3.0.CO;2-N","article-title":"Prognostic factors in local surgical treatment of invasive bladder cancer with special reference to the presence of urothelial dysplasia","volume":"51","author":"Wolf","year":"1983","journal-title":"Cancer"},{"key":"10.1016\/j.clon.2005.07.005_bib3","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0022-5347(17)43864-X","article-title":"Stage T1, grade 3 transitional cell carcinoma of the bladder: an unfavourable tumour?","volume":"137","author":"Jakse","year":"1987","journal-title":"J Urol"},{"key":"10.1016\/j.clon.2005.07.005_bib4","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000472824","article-title":"Radical cystectomy \u2014 often too late?","volume":"13","author":"Stockle","year":"1987","journal-title":"Eur Urol"},{"key":"10.1016\/j.clon.2005.07.005_bib5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0022-5347(17)34865-6","article-title":"Radical cystectomy for stages Ta, Tis and T1 transitional cell carcinoma of the bladder","volume":"151","author":"Amling","year":"1994","journal-title":"J Urol"},{"key":"10.1016\/j.clon.2005.07.005_bib6","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/1097-0142(19950901)76:5<833::AID-CNCR2820760518>3.0.CO;2-M","article-title":"Radical cystectomy for high risk patients with superficial bladder cancer in the era of orthotopic urinary reconstruction","volume":"76","author":"Freeman","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.clon.2005.07.005_bib7","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0022-5347(05)65969-1","article-title":"Clinical understaging of high risk non-muscle invasive urothelial carcinoma treated with radical cystectomy","volume":"166","author":"Dutta","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.clon.2005.07.005_bib8","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1464-410x.2001.02306.x","article-title":"A systematic review of intravesical bacillus calmette-guerin plus transurethral resection vs transurethral resection alone in Ta and T1 bladder cancer","volume":"88","author":"Shelley","year":"2001","journal-title":"BJU Int"},{"issue":"suppl 1","key":"10.1016\/j.clon.2005.07.005_bib9","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000475201","article-title":"BCG in perspective: advances in the treatment of superficial bladder cancer","volume":"27","author":"Lamm","year":"1995","journal-title":"Eur Urol"},{"key":"10.1016\/j.clon.2005.07.005_bib10","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1464-410X.2003.04655.x","article-title":"Intravesical bacillus calmette-guerin is superior to mitomycin-C in reducing tumour recurrence in high risk superficial bladder cancer: a meta-analysis of randomised trials","volume":"93","author":"Shelley","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.clon.2005.07.005_bib11","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/S0022-5347(05)64273-5","article-title":"Intravesical bacillus calmette-guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomised clinical trials","volume":"168","author":"Sylvester","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.clon.2005.07.005_bib12","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1200\/JCO.1987.5.3.441","article-title":"A prospective randomised trial of maintenance vs non-maintenance intravesical bacillus calmette-guerin therapy of superficial bladder cancer","volume":"5","author":"Badalament","year":"1986","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2005.07.005_bib13","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0022-5347(05)67707-5","article-title":"Maintenance bacillus calmette-guerin immunotherapy for recurrent Ta, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomised South West Oncology Group study","volume":"163","author":"Lamm","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.clon.2005.07.005_bib14","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/S0022-5347(05)66333-1","article-title":"Controlled group and maintenance treatment with bacillus calmette-guerin for carcinoma in situ and\/or high grade bladder tumours","volume":"165","author":"Palou","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.clon.2005.07.005_bib15","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0022-5347(05)64044-X","article-title":"A retrospective analysis of 153 patients treated with or without intravesical bacillus calmette-guerin for primary stage T1 grade 3 bladder cancer: recurrence, progression and survival","volume":"169","author":"Shahin","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.clon.2005.07.005_bib16","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1464-410X.1988.tb13968.x","article-title":"The limited usefulness of external beam radiotherapy in the control of superficial bladder cancer","volume":"61","author":"Sawczuk","year":"1988","journal-title":"Br J Urol"},{"key":"10.1016\/j.clon.2005.07.005_bib17","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/j.1464-410X.1975.tb04064.x","article-title":"Flat carcinoma in situ of bladder","volume":"47","author":"Riddle","year":"1975","journal-title":"Br J Urol"},{"key":"10.1016\/j.clon.2005.07.005_bib18","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S0022-5347(17)54123-3","article-title":"Discouraging results for high dose external beam radiation therapy in low stage (0 and A) bladder cancer","volume":"127","author":"Whitmore","year":"1982","journal-title":"J Urol"},{"key":"10.1016\/j.clon.2005.07.005_bib19","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1464-410X.1988.tb13967.x","article-title":"Chemotherapy for carcinoma in situ of bladder","volume":"61","author":"Jenkins","year":"1988","journal-title":"Br J Urol"},{"key":"10.1016\/j.clon.2005.07.005_bib20","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1464-410X.1986.tb09015.x","article-title":"Treatment of superficial (T1) tumours of the bladder by radical radiotherapy","volume":"58","author":"Quilty","year":"1986","journal-title":"Br J Urol"},{"key":"10.1016\/j.clon.2005.07.005_bib22","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/bju.1992.70.5.522","article-title":"Urologists' attitudes to the management of bladder cancer","volume":"70","author":"Lynch","year":"1992","journal-title":"Br J Urol"},{"key":"10.1016\/j.clon.2005.07.005_bib23","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/01.ju.0000132129.87598.3b","article-title":"Primary T1 G3 bladder cancer: organ-preserving approach or immediate cystectomy?","volume":"172","author":"Thalmann","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.clon.2005.07.005_bib24","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/0959-8049(94)90113-9","article-title":"Prognosis and treatment of T1 G3 bladder tumours. A prognostic factor analysis of 121 patients. Dutch South East Bladder Cancer Study Group","volume":"30A","author":"Mulders","year":"1994","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clon.2005.07.005_bib25","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0090-4295(01)01603-X","article-title":"Long-term follow up of G3 T1 transitional cell carcinoma of the bladder treated with intravesical bacille calmette-guerin: 18 year experience","volume":"59","author":"Pansadoro","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.clon.2005.07.005_bib26","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000019664","article-title":"Low dose BCG instillations in the treatment of stage T1 grade 3 bladder tumours: recurrence, progression and success","volume":"34","author":"Lebret","year":"1998","journal-title":"Eur Urol"},{"key":"10.1016\/j.clon.2005.07.005_bib27","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0090-4295(99)00116-8","article-title":"Intravesical bacille calmette-guerin in stage T1 G3 bladder cancer therapy: a 7 year follow up","volume":"54","author":"Hurle","year":"1999","journal-title":"Urology"},{"key":"10.1016\/j.clon.2005.07.005_bib28","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1464-410X.1986.tb05907.x","article-title":"Superficial bladder cancer: intravesical therapy and tumour progression to muscle invasional metastases","volume":"58","author":"Smith","year":"1986","journal-title":"Br J Urol"},{"key":"10.1016\/j.clon.2005.07.005_bib29","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0090-4295(81)90289-2","article-title":"Cystectomy for superficial bladder cancer","volume":"18","author":"Bracken","year":"1981","journal-title":"Urology"},{"key":"10.1016\/j.clon.2005.07.005_bib30","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0090-4295(98)00369-0","article-title":"Intravesical bacillus calmette-guerin treatment for stage T1 grade 3 transitional cell carcinoma of the bladder","volume":"52","author":"Baniel","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.clon.2005.07.005_bib31","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/S0022-5347(05)67523-4","article-title":"Recurrence and progression of stage T1, grade 3 transitional cell carcinoma of the bladder following intravesical immunotherapy with bacillus calmette-guerin","volume":"163","author":"Brake","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.clon.2005.07.005_bib32","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0090-4295(01)01324-3","article-title":"Tumour progression and survival in patients with T1 G3 bladder tumours: multicentric retrospective study comparing 94 patients treated during 17 years","volume":"58","author":"Patard","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.clon.2005.07.005_bib33","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1046\/j.1464-410X.2002.02969.x","article-title":"Recurrence and progression in stage T1 G3 bladder tumour with intravesical bacille calmette-guerin (Danish 1331 strain)","volume":"90","author":"Kulkarni","year":"2002","journal-title":"BJU Int"},{"key":"10.1016\/j.clon.2005.07.005_bib34","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1464-410X.2004.04556.x","article-title":"T1 G3 transitional cell carcinoma of the bladder: recurrence, progression and survival","volume":"93","author":"Peyromaure","year":"2004","journal-title":"BJU Int"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655505002645?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655505002645?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:24:51Z","timestamp":1760541891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655505002645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S0936655505002645"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2005.07.005","relation":{},"ISSN":["0936-6555"],"issn-type":[{"type":"print","value":"0936-6555"}],"subject":[],"published":{"date-parts":[[2005,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Second Look at the pT1 G3 Bladder Tumour","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2005.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}